Superficial bleeding in AHA. Superficial bleeding is common in AHA and will often resolve without hemostatic therapy. The risk of thrombotic complications associated with bypassing agents needs to be weighed against the benefit of treatment, especially in patients with additional risk factors for thrombosis. In contrast, other types of bleeds need prompt treatment.